Oncology, Cardiology and Immunology to Drive the Epigenetics Market

13.03.2019 - 11:19 | 1704138

Artikel von MnM

The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3% from 2017 to 2022.

According to a new market research report "Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022", published by MarketsandMarkets™, the dna methylation market is projected to reach USD 1,605.7 million by 2022 from an estimated USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period.

This report studies the Epigenetics Market based on type, product type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

It focuses on various levels of analysis industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the epigenetics technology market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

This research on epigenomics market provides insights on the following:
Product Development: Product portfolios of the top players in the epigenetics technology market.
Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.

Download an Illustrative Overview of the Report:

Key Market Driving Factors of Epigenomics:

The key factors that are driving the growth of epigenome market include the decreasing sequencing costs and time, increase in research activities to identify and develop inhibitors/drugs for various diseases, funding for epigenetics research, and rising prevalence of cancer.

Biopharmaceutical Companies & Personalized Medicine Driving Growth in (Epigenetics) Genome Market:

According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years. This will further drive the use of epigenetics tools. The expanding application of epigenetics in personalized medicine and targeted therapies, therefore, offers significant opportunities for market growth.

Epigenetics Applications:

Epigenetics has its applications in large number of fields including oncology, drug discovery, disease diagnosis, developmental biology and plant sciences. It is one of the most widely used techniques for cancer biomarkers discovery and development. According to GLOBOCON, 2012 prevalence of cancer is growing. A high prevalence of cancer will majorly drive the epigenetics market. Furthermore, factors such as an increasing research activities and R&D funding by private and government organizations will also aid to the growth of this market.

Request Sample Pages (at)

Research areas of Epigenetics:

The research areas segment will be an important revenue pockets during the forecast period. By research areas, the market is divided into oncology, developmental biology, drug discovery and other epigenetics research areas. Drug discovery segment is expected to grow at a higher rate during the forecast period.
Speak to Subject Expert (at) https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=896

Unternehmensinformation / Kurzprofil:

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales(at)marketsandmarkets.com

PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales(at)marketsandmarkets.com



Vor- / Nachname: MnM

Ansprechpartner: Dheeraj Shaha
Stadt: Northbrook
Telefon: 18886006441

Keywords (optional):
epigenetics-market, epigenetics-market-growth, epigenetics-market-size, epigenetics-market-analysis, epigenetics-market-outlook, epigenetics-market-latest-trends, epigenetics-market-intelligence, epigenetics-market-revenue, epigenetics-market-strategy,

Dieser Artikel wurde bisher 111 mal aufgerufen.


Direkter Link zu diesem Artikel:

Diese Pressemeldung bookmarken bei...

Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.

Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht internet-intelligenz.de

[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]

Alle Artikel von MnM RSS Feed

Ovid Therapeutics präsentiert Ergebnisse am 12. International Epilepsy Colloquium
Amgen gibt empfohlenesöffentliches Barangebot an die Aktionäre von Nuevolution bekannt
3D Cell Culture Market Size, Share | Industry Trends Report
$1,103 million Market Growth Estimated In Bioburden Testing Market
Tandem-Keynote beim 2nd ECP Summer Summit am 26. September 2019

Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by TopBlogs.de